The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Novartis' 2013 sales performance.
Patients and physicians are stronger together and Dunlop, who has more than 20 years’ experience leading patient advocacy programmes and engagement strategies for clients such as AstraZeneca, GSK, Novartis and Pfizer,
Novartis has announced a licence option agreement with Voyager Therapeutics, a gene therapy company focused on next-generation adeno-associated virus (AAV) technologies, for three capsids to use in potential gene ... Voyager will receive an initial $54m
Sandoz, a division of Novartis, is a global company working to address unmet medical needs and provide patients with access to generic pharmaceuticals and biosimilars.
There are no approved treatments, making it ‘one of the most significant unmet needs remaining in retinal diseases’, according to Novartis. ... in ocular gene therapies that will position us well to continue developing this promising one-time
The two companies are already working together after Novartis signed an in-licensing agreement for BeiGene’s anti-PD-1 monoclonal antibody, tislelizumab. ... countries. Basel-based Novartis will also pay a fee of up to $700m if the option is exercised
[ Previous 5 results ] 6 7 8 9 10 11 12 13 14 15 [ Next 5 results ]
We are Evoke Mind ‘PLUS’ Matter. The ‘plus’ is important to us because we are all about offering more for...